Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft.

DiGiovanni CW, Lin SS, Baumhauer JF, Daniels T, Younger A, Glazebrook M, Anderson J, Anderson R, Evangelista P, Lynch SE; North American Orthopedic Foot and Ankle Study Group.

J Bone Joint Surg Am. 2013 Jul 3;95(13):1184-92. doi: 10.2106/JBJS.K.01422.

PMID:
23824386
2.

Prospective Randomized Controlled Trial of Hindfoot and Ankle Fusions Treated With rhPDGF-BB in Combination With a β-TCP-Collagen Matrix.

Daniels TR, Younger AS, Penner MJ, Wing KJ, Le IL, Russell IS, Lalonde KA, Evangelista PT, Quiton JD, Glazebrook M, DiGiovanni CW.

Foot Ankle Int. 2015 Jul;36(7):739-48. doi: 10.1177/1071100715576370. Epub 2015 Apr 6.

PMID:
25848134
4.

Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.

Nevins M, Giannobile WV, McGuire MK, Kao RT, Mellonig JT, Hinrichs JE, McAllister BS, Murphy KS, McClain PK, Nevins ML, Paquette DW, Han TJ, Reddy MS, Lavin PT, Genco RJ, Lynch SE.

J Periodontol. 2005 Dec;76(12):2205-15.

PMID:
16332231
5.

Prospective, randomized, multi-center feasibility trial of rhPDGF-BB versus autologous bone graft in a foot and ankle fusion model.

Digiovanni CW, Baumhauer J, Lin SS, Berberian WS, Flemister AS, Enna MJ, Evangelista P, Newman J.

Foot Ankle Int. 2011 Apr;32(4):344-54. doi: 10.3113/FAI.2011.0344.

PMID:
21733435
6.

Impact of recombinant platelet-derived growth factor BB on bone regeneration: a study in rabbits.

Thoma DS, Jung RE, Hänseler P, Hämmerle CH, Cochran DL, Weber FE.

Int J Periodontics Restorative Dent. 2012 Apr;32(2):195-202.

PMID:
22292149
8.

Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study.

Solchaga LA, Daniels T, Roach S, Beasley W, Snel LB.

Clin Drug Investig. 2013 Feb;33(2):143-9. doi: 10.1007/s40261-013-0053-5.

PMID:
23334906
9.

Prospective clinical pilot trial in a single cohort group of rhPDGF in foot arthrodeses.

Daniels T, DiGiovanni C, Lau JT, Wing K, Younger A.

Foot Ankle Int. 2010 Jun;31(6):473-9. doi: 10.3113/FAI.2010.0473.

PMID:
20557811
10.
11.

Percutaneous injection of augment injectable bone graft (rhPDGF-BB and β-tricalcium phosphate [β-TCP]/bovine type I collagen matrix) increases vertebral bone mineral density in geriatric female baboons.

Perrien DS, Young CS, Alvarez-Urena PP, Dean DD, Lynch SE, Hollinger JO.

Spine J. 2013 May;13(5):580-6. doi: 10.1016/j.spinee.2013.02.029. Epub 2013 Mar 27.

PMID:
23541446
12.

Growth factor-mediated treatment of recession defects: a randomized controlled trial and histologic and microcomputed tomography examination.

McGuire MK, Scheyer ET, Schupbach P.

J Periodontol. 2009 Apr;80(4):550-64. doi: 10.1902/jop.2009.080502.

PMID:
19335074
13.

Effect of β tricalcium phosphate particle size on recombinant human platelet-derived growth factor-BB-induced regeneration of periodontal tissue in dog.

Irokawa D, Ota M, Yamamoto S, Shibukawa Y, Yamada S.

Dent Mater J. 2010 Nov;29(6):721-30. Epub 2010 Nov 19.

14.

The combination of purified recombinant human platelet-derived growth factor-BB and equine particulate bone graft for periodontal regeneration.

Nevins M, Nevins ML, Karimbux N, Kim SW, Schupbach P, Kim DM.

J Periodontol. 2012 May;83(5):565-73. doi: 10.1902/jop.2011.110298. Epub 2011 Oct 20.

PMID:
22014175
15.

rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations.

McGuire MK, Kao RT, Nevins M, Lynch SE.

Int J Periodontics Restorative Dent. 2006 Jun;26(3):223-31. Erratum in: Int J Periodontics Restorative Dent. 2007 Feb;27(1):88.

PMID:
16836164
16.

The evolution of rhPDGF-BB in musculoskeletal repair and its role in foot and ankle fusion surgery.

DiGiovanni CW, Petricek JM.

Foot Ankle Clin. 2010 Dec;15(4):621-40. doi: 10.1016/j.fcl.2010.07.001. Review.

PMID:
21056861
17.

Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with Augment(TM) Bone Graft or GEM 21S beta-tricalcium phosphate (beta-TCP).

Young CS, Ladd PA, Browning CF, Thompson A, Bonomo J, Shockley K, Hart CE.

J Control Release. 2009 Dec 16;140(3):250-5. doi: 10.1016/j.jconrel.2009.06.030. Epub 2009 Jul 3.

PMID:
19577598
18.

Clinical assessment of bone quality of human extraction sockets after conversion with growth factors.

Ntounis A, Geurs N, Vassilopoulos P, Reddy M.

Int J Oral Maxillofac Implants. 2015 Jan-Feb;30(1):196-201. doi: 10.11607/jomi.3518. Epub 2014 Sep 26.

PMID:
25265123
19.

New composite endpoints to assess efficacy in periodontal therapy clinical trials.

Lynch SE, Lavin PT, Genco RJ, Beasley WG, Wisner-Lynch LA.

J Periodontol. 2006 Aug;77(8):1314-22.

PMID:
16881800
20.

Beta tricalcium phosphate: observation of use in 100 posterolateral lumbar instrumented fusions.

Epstein NE.

Spine J. 2009 Aug;9(8):630-8. doi: 10.1016/j.spinee.2009.04.007. Epub 2009 Jun 4.

PMID:
19501025
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk